Back to Search
CHRISTOPHER TAKIMOTO, M.D.
M.D.
Medical Oncology Physician
NPI: 1841293321Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
L1212(TX)
Research & Publications (20)
Phase 0 clinical trials in oncology: a paradigm shift for early drug development?
PMID 18615251·Cancer Chemother Pharmacol·2009
6-review
Safety and anti-tumor activity of sorafenib (Nexavar) in combination with other anti-cancer agents: a review of clinical trials.
PMID 18026728·Cancer Chemother Pharmacol·2008
6-review
Oxaliplatin pharmacokinetics and pharmacodynamics in adult cancer patients with impaired renal function.
PMID 17699862·Clin Cancer Res·2007
8-other
Phase I and pharmacokinetic study of pemetrexed with high-dose folic acid supplementation or multivitamin supplementation in patients with locally advanced or metastatic cancer.
PMID 17473199·Clin Cancer Res·2007
3-trial
Can tamoxifen therapy be optimized for patients with breast cancer on the basis of CYP2D6 activity assessments?
PMID 17245346·Nat Clin Pract Oncol·2007
8-other
Chronomodulated chemotherapy for colorectal cancer: failing the test of time?
PMID 16439112·Eur J Cancer·2006
6-review
Can docetaxel dosing be individualized based on cytochrome p450 activity?
PMID 16265013·Nat Clin Pract Oncol·2005
8-other
Are there any better camptothecins than the ones we have?
PMID 16258452·Clin Adv Hematol Oncol·2003
8-other
Epidermal growth factor receptor and other molecular targets in the treatment of cancer.
PMID 12620147·Clin Colorectal Cancer·2003
8-other
Anticancer drug development at the US National Cancer Institute.
PMID 12819935·Cancer Chemother Pharmacol·2003
7-preclinical
Dose-escalating and pharmacological study of oxaliplatin in adult cancer patients with impaired renal function: a National Cancer Institute Organ Dysfunction Working Group Study.
PMID 12860942·J Clin Oncol·2003
3-trial
Heat shock protein and proteasome targeting agents.
PMID 12512392·Hematol Oncol Clin North Am·2002
6-review
Thymidylate Synthase Pharmacogenetics in Colorectal Cancer.
PMID 12450434·Clin Colorectal Cancer·2001
8-other
Mechanism-based receptor-binding model to describe the pharmacokinetic and pharmacodynamic of an anti-α5β1 integrin monoclonal antibody (volociximab) in cancer patients.
PMID 19468731·Cancer Chemother Pharmacol·2010
3-trial
Phase I and pharmacokinetic study of cisplatin and troxacitabine administered intravenously every 28 days in patients with advanced solid malignancies.
PMID 19449006·Cancer Chemother Pharmacol·2009
3-trial
Phase II study of sorafenib in patients with metastatic or recurrent sarcomas.
PMID 19451436·J Clin Oncol·2009
3-trial
A phase I study of eribulin mesylate (E7389), a mechanistically novel inhibitor of microtubule dynamics, in patients with advanced solid malignancies.
PMID 19509177·Clin Cancer Res·2009
3-trial
Castration-resistant prostate cancer: locking up the molecular escape routes.
PMID 19447877·Clin Cancer Res·2009
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 7979 WURZBACH RD, Z 4TH FLOOR
SAN ANTONIO, TX 78229 - Phone
- (210) 450-1725
Quick Facts
- NPI
- 1841293321
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile